换一批2014年第43卷19期
共12篇1. P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases. 6716-26页
作者：Andrew A,Pieper； Steven L,McKnight； Joseph M,Ready
2. Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain. 6814-38页
作者：Paramita,Mukherjee； Maris A,Cinelli； Soosung,Kang； Richard B,Silverman
3. Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. 6692-700页
作者：Samuel A,Kotler； Patrick,Walsh； Jeffrey R,Brender； Ayyalusamy,Ramamoorthy
4. Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease. 6701-15页
作者：David J,Hayne； SinChun,Lim； Paul S,Donnelly
5. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. 6765-813页
作者：Arun K,Ghosh； Heather L,Osswald
6. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond. 6839-58页
作者：Scott A,Yuzwa； David J,Vocadlo
7. Biological metals and metal-targeting compounds in major neurodegenerative diseases. 6727-49页
作者：Kevin J,Barnham； Ashley I,Bush
8. Cholesterol and metal ions in Alzheimer's disease. 6672-82页
作者：Hyuck Jin,Lee； Kyle J,Korshavn； Akiko,Kochi； Jeffrey S,Derrick； Mi Hee,Lim
9. PET/SPECT imaging agents for neurodegenerative diseases. 6683-91页
作者：Lin,Zhu； Karl,Ploessl； Hank F,Kung
10. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. 6859-69页
作者：Rebecca A,Kohnz； Daniel K,Nomura
